Maureen P. Boyle, Ph.D. - Publications

Affiliations: 
Washington University, Saint Louis, St. Louis, MO 
Area:
Endocrinology and Stress

70/83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Boyle MP. The Evidence for Long-Term Benefits of Restoration of CFTR Function Continues to Grow. American Journal of Respiratory and Critical Care Medicine. 192: 774-6. PMID 26426780 DOI: 10.1164/rccm.201507-1348ED  0.08
2015 Mastorakos P, da Silva AL, Chisholm J, Song E, Choi WK, Boyle MP, Morales MM, Hanes J, Suk JS. Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 26124127 DOI: 10.1073/Pnas.1502281112  0.08
2015 Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, ... Boyle MP, et al. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. The New England Journal of Medicine. 373: 220-31. PMID 25981758 DOI: 10.1056/Nejmoa1409547  0.08
2015 Boyle MP. Identifying correlates of self-stigma in adults who stutter: Further establishing the construct validity of the Self-Stigma of Stuttering Scale (4S). Journal of Fluency Disorders. 43: 17-27. PMID 25614323 DOI: 10.1016/j.jfludis.2014.12.002  0.08
2015 Boyle MP. Relationships between psychosocial factors and quality of life for adults who stutter. American Journal of Speech-Language Pathology / American Speech-Language-Hearing Association. 24: 1-12. PMID 25410098 DOI: 10.1044/2014_AJSLP-14-0089  0.08
2014 Boyle MP. Understanding perceptions of stuttering among school-based speech-language pathologists: an application of attribution theory. Journal of Communication Disorders. 52: 143-55. PMID 25042750 DOI: 10.1016/j.jcomdis.2014.06.003  0.04
2014 Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM, Rietschel E, Huang X, Waltz D, Patel NR, Rodman D. A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial. The Lancet. Respiratory Medicine. 2: 527-38. PMID 24973281 DOI: 10.1016/S2213-2600(14)70132-8  0.08
2014 Jennings MT, Boyle MP, Weaver D, Callahan KA, Dasenbrook EC. Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial. Trials. 15: 223. PMID 24925006 DOI: 10.1186/1745-6215-15-223  0.01
2014 Schuster BS, Kim AJ, Kays JC, Kanzawa MM, Guggino WB, Boyle MP, Rowe SM, Muzyczka N, Suk JS, Hanes J. Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1484-93. PMID 24869933 DOI: 10.1038/Mt.2014.89  0.08
2014 Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, Roy S, Wynshaw-Boris A, Colamarino SA, Lein ES, Courchesne E. Patches of disorganization in the neocortex of children with autism. The New England Journal of Medicine. 370: 1209-19. PMID 24670167 DOI: 10.1056/Nejmoa1307491  0.72
2014 Boyle MP, Sabadosa KA, Quinton HB, Marshall BC, Schechter MS. Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project. Bmj Quality & Safety. 23: i15-i22. PMID 24608546 DOI: 10.1136/bmjqs-2013-002369  0.08
2014 Suk JS, Kim AJ, Trehan K, Schneider CS, Cebotaru L, Woodward OM, Boylan NJ, Boyle MP, Lai SK, Guggino WB, Hanes J. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier. Journal of Controlled Release : Official Journal of the Controlled Release Society. 178: 8-17. PMID 24440664 DOI: 10.1016/J.Jconrel.2014.01.007  0.08
2014 Jennings MT, Riekert KA, Boyle MP. Update on key emerging challenges in cystic fibrosis. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. 23: 393-402. PMID 24434297 DOI: 10.1159/000357646  0.08
2013 Boyle MP, De Boeck K. A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect. The Lancet. Respiratory Medicine. 1: 158-63. PMID 24429096 DOI: 10.1016/S2213-2600(12)70057-7  0.01
2013 Boyle MP. Psychological characteristics and perceptions of stuttering of adults who stutter with and without support group experience. Journal of Fluency Disorders. 38: 368-81. PMID 24331244 DOI: 10.1016/j.jfludis.2013.09.001  0.08
2013 Lechtzin N, West N, Allgood S, Wilhelm E, Khan U, Mayer-Hamblett N, Aitken ML, Ramsey BW, Boyle MP, Mogayzel PJ, Goss CH. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial. Contemporary Clinical Trials. 36: 460-9. PMID 24055998 DOI: 10.1016/J.Cct.2013.09.004  0.08
2013 Boyle MP. Assessment of stigma associated with stuttering: development and evaluation of the self-stigma of stuttering scale (4S). Journal of Speech, Language, and Hearing Research : Jslhr. 56: 1517-29. PMID 23838992 DOI: 10.1044/1092-4388(2013/12-0280)  0.04
2013 Blood GW, Blood IM, Coniglio AD, Finke EH, Boyle MP. Familiarity breeds support: speech-language pathologists' perceptions of bullying of students with autism spectrum disorders. Journal of Communication Disorders. 46: 169-80. PMID 23497960 DOI: 10.1016/J.Jcomdis.2013.01.002  0.01
2012 Boylan NJ, Suk JS, Lai SK, Jelinek R, Boyle MP, Cooper MJ, Hanes J. Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 157: 72-9. PMID 21903145 DOI: 10.1016/J.Jconrel.2011.08.031  0.08
2012 Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, De Boeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, et al. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 67: 12-8. PMID 21825083 DOI: 10.1136/Thoraxjnl-2011-200393  0.08
2011 Suk JS, Boylan NJ, Trehan K, Tang BC, Schneider CS, Lin JM, Boyle MP, Zeitlin PL, Lai SK, Cooper MJ, Hanes J. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1981-9. PMID 21829177 DOI: 10.1038/Mt.2011.160  0.08
2011 Hida K, Lai SK, Suk JS, Won SY, Boyle MP, Hanes J. Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients. Plos One. 6: e19919. PMID 21637751 DOI: 10.1371/Journal.Pone.0019919  0.08
2011 Boyle MP, Bernard A, Thompson CL, Ng L, Boe A, Mortrud M, Hawrylycz MJ, Jones AR, Hevner RF, Lein ES. Cell-type-specific consequences of Reelin deficiency in the mouse neocortex, hippocampus, and amygdala. The Journal of Comparative Neurology. 519: 2061-89. PMID 21491433 DOI: 10.1002/Cne.22655  0.72
2011 Eakin MN, Bilderback A, Boyle MP, Mogayzel PJ, Riekert KA. Longitudinal association between medication adherence and lung health in people with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: 258-64. PMID 21458391 DOI: 10.1016/j.jcf.2011.03.005  0.08
2011 West NE, Lechtzin N, Merlo CA, Turowski JB, Davis ME, Ramsay MZ, Watts SL, Stenner SP, Boyle MP. Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis. Chest. 140: 469-74. PMID 21393390 DOI: 10.1378/chest.10-2114  0.01
2011 Suk JS, Lai SK, Boylan NJ, Dawson MR, Boyle MP, Hanes J. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomedicine (London, England). 6: 365-75. PMID 21385138 DOI: 10.2217/Nnm.10.123  0.08
2011 Lin D, Boyle MP, Dollar P, Lee H, Lein ES, Perona P, Anderson DJ. Functional identification of an aggression locus in the mouse hypothalamus. Nature. 470: 221-6. PMID 21307935 DOI: 10.1038/nature09736  0.72
2011 Arnett MG, Kolber BJ, Boyle MP, Muglia LJ. Behavioral insights from mouse models of forebrain--and amygdala-specific glucocorticoid receptor genetic disruption. Molecular and Cellular Endocrinology. 336: 2-5. PMID 21094675 DOI: 10.1016/J.Mce.2010.11.011  0.72
2010 Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, Moss RB, Pilewski JM, Rubenstein RC, Uluer AZ, Aitken ML, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. The New England Journal of Medicine. 363: 1991-2003. PMID 21083385 DOI: 10.1056/Nejmoa0909825  0.08
2010 Modi AC, Quittner AL, Boyle MP. Assessing disease disclosure in adults with cystic fibrosis: the Adult Data for Understanding Lifestyle and Transitions (ADULT) survey Disclosure of disease in adults with cystic fibrosis. Bmc Pulmonary Medicine. 10: 46. PMID 20831811 DOI: 10.1186/1471-2466-10-46  0.08
2010 Boyle MP. Cystic fibrosis: year in review. Current Opinion in Pulmonary Medicine. 16: 583. PMID 20829695 DOI: 10.1097/MCP.0b013e32833f3f0d  0.01
2010 Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. Jama. 303: 2386-92. PMID 20551409 DOI: 10.1001/jama.2010.791  0.08
2010 Kolber BJ, Boyle MP, Wieczorek L, Kelley CL, Onwuzurike CC, Nettles SA, Vogt SK, Muglia LJ. Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2571-81. PMID 20164342 DOI: 10.1523/Jneurosci.4470-09.2010  0.72
2010 Sudfeld CR, Dasenbrook EC, Merz WG, Carroll KC, Boyle MP. Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 9: 110-6. PMID 20045384 DOI: 10.1016/j.jcf.2009.11.010  0.01
2009 Tang BC, Dawson M, Lai SK, Wang YY, Suk JS, Yang M, Zeitlin P, Boyle MP, Fu J, Hanes J. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proceedings of the National Academy of Sciences of the United States of America. 106: 19268-73. PMID 19901335 DOI: 10.1073/Pnas.0905998106  0.08
2009 Wu Q, Boyle MP, Palmiter RD. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell. 137: 1225-34. PMID 19563755 DOI: 10.1016/J.Cell.2009.04.022  0.72
2009 Suk JS, Lai SK, Wang YY, Ensign LM, Zeitlin PL, Boyle MP, Hanes J. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials. 30: 2591-7. PMID 19176245 DOI: 10.1016/J.Biomaterials.2008.12.076  0.08
2008 Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 178: 814-21. PMID 18669817 DOI: 10.1164/Rccm.200802-327Oc  0.08
2008 McLaughlin SE, Diener-West M, Indurkhya A, Rubin H, Heckmann R, Boyle MP. Improving transition from pediatric to adult cystic fibrosis care: lessons from a national survey of current practices. Pediatrics. 121: e1160-6. PMID 18450860 DOI: 10.1542/Peds.2007-2217  0.08
2007 Boyle MP. Adult cystic fibrosis. Jama. 298: 1787-93. PMID 17940235 DOI: 10.1001/jama.298.15.1787  0.16
2007 Hsu SC, Groman JD, Merlo CA, Naughton K, Zeitlin PL, Germain-Lee EL, Boyle MP, Cutting GR. Patients with mutations in Gsalpha have reduced activation of a downstream target in epithelial tissues due to haploinsufficiency. The Journal of Clinical Endocrinology and Metabolism. 92: 3941-8. PMID 17652219 DOI: 10.1210/Jc.2007-0271  0.08
2007 Merlo CA, Boyle MP, Diener-West M, Marshall BC, Goss CH, Lechtzin N. Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis. Chest. 132: 562-8. PMID 17646236 DOI: 10.1378/Chest.06-2888  0.08
2007 Riekert KA, Bartlett SJ, Boyle MP, Krishnan JA, Rand CS. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest. 132: 231-7. PMID 17625085 DOI: 10.1378/chest.06-2474  0.08
2007 Lee CK, Boyle MP, Diener-West M, Brass-Ernst L, Noschese M, Zeitlin PL. Levofloxacin pharmacokinetics in adult cystic fibrosis. Chest. 131: 796-802. PMID 17356095 DOI: 10.1378/Chest.06-1524  0.08
2007 Boyle MP. Strategies for identifying modifier genes in cystic fibrosis. Proceedings of the American Thoracic Society. 4: 52-7. PMID 17202292 DOI: 10.1513/pats.200605-129JG  0.12
2007 Buranawuti K, Boyle MP, Cheng S, Steiner LL, McDougal K, Fallin MD, Merlo C, Zeitlin PL, Rosenstein BJ, Mogayzel PJ, Wang X, Cutting GR. Variants in mannose-binding lectin and tumour necrosis factor alpha affect survival in cystic fibrosis. Journal of Medical Genetics. 44: 209-14. PMID 17158822 DOI: 10.1136/Jmg.2006.046318  0.08
2006 Boyle MP. Update on maintaining bone health in cystic fibrosis. Current Opinion in Pulmonary Medicine. 12: 453-8. PMID 17053497 DOI: 10.1097/01.mcp.0000245708.59138.a4  0.12
2006 Boyle MP, Enke RA, Reynolds JB, Mogayzel PJ, Guggino WB, Zeitlin PL. Membrane-associated heparan sulfate is not required for rAAV-2 infection of human respiratory epithelia. Virology Journal. 3: 29. PMID 16630361 DOI: 10.1186/1743-422X-3-29  0.08
2006 Wright JM, Merlo CA, Reynolds JB, Zeitlin PL, Garcia JG, Guggino WB, Boyle MP. Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease. American Journal of Respiratory Cell and Molecular Biology. 35: 327-36. PMID 16614352 DOI: 10.1165/Rcmb.2005-0359Oc  0.08
2006 Boyle MP, Kolber BJ, Vogt SK, Wozniak DF, Muglia LJ. Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1971-8. PMID 16481429 DOI: 10.1523/Jneurosci.2173-05.2006  0.72
2006 Lechtzin N, John M, Irizarry R, Merlo C, Diette GB, Boyle MP. Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa. Respiration; International Review of Thoracic Diseases. 73: 27-33. PMID 16113513 DOI: 10.1159/000087686  0.01
2005 Drenan RM, Doupnik CA, Boyle MP, Muglia LJ, Huettner JE, Linder ME, Blumer KJ. Palmitoylation regulates plasma membrane-nuclear shuttling of R7BP, a novel membrane anchor for the RGS7 family. The Journal of Cell Biology. 169: 623-33. PMID 15897264 DOI: 10.1083/Jcb.200502007  0.72
2005 Boyle MP, Noschese ML, Watts SL, Davis ME, Stenner SE, Lechtzin N. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 172: 212-7. PMID 15860755 DOI: 10.1164/rccm.200403-387OC  0.01
2005 Boyle MP, Brewer JA, Funatsu M, Wozniak DF, Tsien JZ, Izumi Y, Muglia LJ. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proceedings of the National Academy of Sciences of the United States of America. 102: 473-8. PMID 15623560 DOI: 10.1073/Pnas.0406458102  0.72
2004 Boyle MP, Brewer JA, Vogt SK, Wozniak DF, Muglia LJ. Genetic dissection of stress response pathways in vivo. Endocrine Research. 30: 859-63. PMID 15666837 DOI: 10.1081/Erc-200044120  0.72
2004 Wozniak DF, Hartman RE, Boyle MP, Vogt SK, Brooks AR, Tenkova T, Young C, Olney JW, Muglia LJ. Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiology of Disease. 17: 403-14. PMID 15571976 DOI: 10.1016/J.Nbd.2004.08.006  0.72
2004 Zeitlin PL, Boyle MP, Guggino WB, Molina L. A phase I trial of intranasal Moli1901 for cystic fibrosis. Chest. 125: 143-9. PMID 14718433 DOI: 10.1378/Chest.125.1.143  0.08
2003 Boyle MP, Orens JB. Distal intestinal obstruction syndrome after surgery in cystic fibrosis. Chest. 124: 2408-9. PMID 14665537 DOI: 10.1378/CHEST.124.6.2408-B  0.01
2003 Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Current Opinion in Pulmonary Medicine. 9: 498-503. PMID 14534402 DOI: 10.1097/00063198-200311000-00009  0.04
2003 Boyle MP, Diener-West M, Milgram L, Knowles M, Foy C, Zeitlin P, Standaert T. A multicenter study of the effect of solution temperature on nasal potential difference measurements. Chest. 124: 482-9. PMID 12907532 DOI: 10.1378/Chest.124.2.482  0.08
2003 Merlo CA, Boyle MP. Modifier genes in cystic fibrosis lung disease. The Journal of Laboratory and Clinical Medicine. 141: 237-41. PMID 12677168 DOI: 10.1067/mlc.2003.29  0.01
2003 Boyle MP, Enke RA, Mogayzel PJ, Guggino WB, Martin DB, Agarwal S, Zeitlin PL. Effect of adeno-associated virus-specific immunoglobulin G in human amniotic fluid on gene transfer. Human Gene Therapy. 14: 365-73. PMID 12659677 DOI: 10.1089/104303403321208961  0.08
2003 Boyle MP. So many drugs, so little time: the future challenge of cystic fibrosis care. Chest. 123: 3-5. PMID 12527590 DOI: 10.1378/CHEST.123.1.3  0.04
2002 Zeitlin PL, Diener-West M, Rubenstein RC, Boyle MP, Lee CK, Brass-Ernst L. Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 119-26. PMID 12095312 DOI: 10.1006/Mthe.2002.0639  0.08
2001 Boyle MP, Farukhi Z, Nosky ML. Strategies for improving transition to adult cystic fibrosis care, based on patient and parent views. Pediatric Pulmonology. 32: 428-36. PMID 11747245 DOI: 10.1002/ppul.1154  0.01
2001 Boyle MP, Enke RA, Adams RJ, Guggino WB, Zeitlin PL. In utero AAV-mediated gene transfer to rabbit pulmonary epithelium. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 115-21. PMID 11482982 DOI: 10.1006/Mthe.2001.0428  0.08
2001 Boyle MP. The spectrum of CFTR-related disease. Internal Medicine (Tokyo, Japan). 40: 522-5. PMID 11446679 DOI: 10.2169/INTERNALMEDICINE.40.522  0.16
2001 Boyle MP. Minocycline-induced pancreatitis in cystic fibrosis. Chest. 119: 1283-5. PMID 11296204 DOI: 10.1378/chest.119.4.1283  0.08
2000 Boyle MP. Unique presentations and chronic complications in adult cystic fibrosis: do they teach us anything about CFTR? Respiratory Research. 1: 133-5. PMID 11667976 DOI: 10.1186/rr23  0.12
1993 Boyle MP, Weisman HF. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation. 88: 2872-83. PMID 8252700 DOI: 10.1161/01.CIR.88.6.2872  0.01
Low-probability matches
2011 Boyle MP. Mindfulness training in stuttering therapy: a tutorial for speech-language pathologists. Journal of Fluency Disorders. 36: 122-9. PMID 21664530 DOI: 10.1016/j.jfludis.2011.04.005  0.04
2005 Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, Guise TA, Hardin DS, Haworth CS, Holick MF, Joseph PM, O'Brien K, Tullis E, Watts NB, White TB. Guide to bone health and disease in cystic fibrosis. The Journal of Clinical Endocrinology and Metabolism. 90: 1888-96. PMID 15613415 DOI: 10.1210/Jc.2004-1629  0.08
1990 Weisman HF, Bartow T, Leppo MK, Marsh HC, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science (New York, N.Y.). 249: 146-51. PMID 2371562 DOI: 10.1126/Science.2371562  0.08
1990 Weisman HF, Bartow T, Leppo MK, Boyle MP, Marsh HC, Carson GR, Roux KH, Weisfeldt ML, Fearon DT. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium. Transactions of the Association of American Physicians. 103: 64-72. PMID 2132543  0.08
2009 Boyle MP, Blood GW, Blood IM. Effects of perceived causality on perceptions of persons who stutter. Journal of Fluency Disorders. 34: 201-18. PMID 19948273 DOI: 10.1016/J.Jfludis.2009.09.003  0.01
2014 Finley JB, Boyle MP. The frequency and typology of ceramic sites in western Wyoming Plains Anthropologist. 59: 38-57. DOI: 10.1179/2052546X13Y.0000000006  0.01
2012 Thomas JA, Boyle MP, Hunter LW, Tiffany JE. Temperature sensitivity of capillary-driven flow: application to age monitoring devices. Journal of Colloid and Interface Science. 372: 176-82. PMID 22300654 DOI: 10.1016/j.jcis.2012.01.008  0.01
2012 Potter SM, Dwyer RM, Hartmann MC, Khan S, Boyle MP, Curran CE, Kerin MJ. Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo. Breast Cancer Research and Treatment. 131: 401-11. PMID 21344235 DOI: 10.1007/s10549-011-1410-9  0.01
2011 Blood GW, Blood IM, Tramontana GM, Sylvia AJ, Boyle MP, Motzko GR. Self-reported experience of bullying of students who stutter: relations with life satisfaction, life orientation, and self-esteem. Perceptual and Motor Skills. 113: 353-64. PMID 22185050 DOI: 10.2466/07.10.15.17.Pms.113.5.353-364  0.01
2010 Blood GW, Boyle MP, Blood IM, Nalesnik GR. Bullying in children who stutter: speech-language pathologists' perceptions and intervention strategies. Journal of Fluency Disorders. 35: 92-109. PMID 20609331 DOI: 10.1016/J.Jfludis.2010.03.003  0.01
2006 Au K, Berrow NS, Blagova E, Boucher IW, Boyle MP, Brannigan JA, Carter LG, Dierks T, Folkers G, Grenha R, Harlos K, Kaptein R, Kalliomaa AK, Levdikov VM, Meier C, et al. Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis. Acta Crystallographica. Section D, Biological Crystallography. 62: 1267-75. PMID 17001104 DOI: 10.1107/S0907444906033555  0.01
2005 Boyle MP, Kalliomaa AK, Levdikov V, Blagova E, Fogg MJ, Brannigan JA, Wilson KS, Wilkinson AJ. Crystal structure of PurE (BA0288) from Bacillus anthracis at 1.8 A resolution. Proteins. 61: 674-6. PMID 16138311 DOI: 10.1002/prot.20599  0.01
1981 Boyle MP, Koff E, Gudas LJ. Assessment and management of anorexia nervosa. McN. the American Journal of Maternal Child Nursing. 6: 412-8. PMID 6795415  0.01
Hide low-probability matches.